PLK4 and thyroid gland undifferentiated (anaplastic) carcinoma: The anti-tumor effect of polo-like kinase 4 (PLK4) inhibitor has been explored in several solid carcinomas, while its application in anaplastic thyroid cancer (ATC) remains scarce.